ProFIT Brandenburg: Non Dilutive Funding for Our Heart Failure Research
ProFIT Brandenburg: Non Dilutive Funding for Our Heart Failure Research
Heart failure is frequently marked by gradual clinical deterioration that often goes undetected until acute decompensation makes hospitalization unavoidable. Our research focuses on identifying these early signs of worsening and supporting guideline-directed therapy in telemonitoring. The ProFIT Brandenburg funding program supports the continued development of this work.
Through ProFIT, the State of Brandenburg and the European Union support innovative research and development projects. Noah Labs has received funding for two projects so far, with one completed and a second ongoing. We are very grateful for this support.
Ongoing ProFIT Brandenburg Project
Project: R&D of an autonomous, AI-based treatment system for guideline-compliant therapy optimization for heart failure patients
Research and development of an autonomous, AI-based treatment system for guideline-compliant therapy optimization for heart failure patients in telemonitoring. As part of the project, the technology is being developed for two separate but complementary products, which will be marketed independently of each other:
- Product 1: Implant-based early warning system (NL Cor)
- Product 2: Closed-loop HF management (NL Liv)
Completed ProFIT Brandenburg Project
Project: Noah Labs Pre-Sense: Multiparametric application for the early detection of cardiac decompensation
Research and development of an innovative application that uses a multiparametric machine learning system to analyze patients’ vital signs, voice characteristics and symptoms, providing early warning of cardiac decompensation.
Both projects share the same goal: detecting worsening heart failure earlier, so that patients get the right care in time. We thank the State of Brandenburg, the European Union and the Bradenburg Investment Bank (ILB) for their trust.
Funded by the State of Brandenburg and the European Union (ERDF).